A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor

NCT05997342 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Neoplasm

Interventions

DRUG: TQB3912 tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.